| 李晓红,安健,王馨,郭峥.CYP2C19检测对高危PCI患者抗血小板治疗的临床意义及成本效益分析[J].中国心血管病研究,2017,15(12): |
| CYP2C19检测对高危PCI患者抗血小板治疗的临床意义及成本效益分析 |
| The clinical significance and cost effectiveness analysis of the CYP2C19 detect application in patients with high-risk PCI to antiplatelet therapy |
| 投稿时间：2017-07-12 修订日期：2017-11-06 |
| 关闭 |
|
|
|
